REGENXBIO Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for REGENXBIO stock have an average target of 32.89, with a low estimate of 14 and a high estimate of 52. The average target predicts an increase of 371.20% from the current stock price of 6.98.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$14	$32.89	$34	$52
Change	+100.57%	+371.20%	+387.11%	+644.99%

Analyst Ratings

The average analyst rating for REGENXBIO stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	4	4	4	4	3	4
Buy	6	7	7	7	7	4
Hold	1	1	1	1	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	12	12	12	12	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $34	Strong Buy	Reiterates	$34	+387.11%	Mar 21, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $34	Strong Buy	Reiterates	$34	+387.11%	Mar 20, 2025
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy Maintains $52	Strong Buy	Maintains	$52	+644.99%	Mar 20, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $36 → $34	Strong Buy	Maintains	$36 → $34	+387.11%	Mar 17, 2025
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy Maintains $52	Strong Buy	Maintains	$52	+644.99%	Mar 14, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

320.81M

from 83.33M

285.00%

from 83.33M

Revenue Next Year

186.41M

from 320.81M

-41.89%

from 320.81M

EPS This Year

-0.44

from -4.59

EPS Next Year

-2.13

from -0.44

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	154.57M	470.35M	112.72M	90.24M	83.33M	320.81M	186.41M	408.39M
Revenue Growth	338.70%	204.30%	-76.03%	-19.94%	-7.66%	285.00%	-41.89%	119.08%
EPS	-2.98	2.91	-6.50	-6.02	-4.59	-0.44	-2.13	-1.69
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	12	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	520.3M	367.7M	609.1M
Avg	320.8M	186.4M	408.4M
Low	198.8M	107.8M	253.2M

Revenue Growth

Revenue Growth	2025	2026	2027
High	524.4%	14.6%	226.8%
Avg	285.0%	-41.9%	119.1%
Low	138.6%	-66.4%	35.8%

EPS Forecast

EPS	2025	2026	2027
High	2.61	1.13	2.46
Avg	-0.44	-2.13	-1.69
Low	-4.70	-5.50	-3.94

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.